Maxim Boosts Estimates, Affirms Galena (GALE) at 'Buy' Following Q1 Results
Tweet Send to a Friend
Maxim affirms its Buy rating and $11 price target on Galena Biopharma, Inc. (Nasdaq: GALE) following Q1 results.Analyst Echo He ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
